Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/03 → 31/12/05 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$465,000.00
Development and evaluation of biological reagents targetting and inhibiting function of the EphA3 receptor on tumour cells
- Lackmann, Martin (Primary Chief Investigator (PCI))
- Lee, Fook-Thean (Chief Investigator (CI))
- Scott, Andrew Mark (Chief Investigator (CI))
Project: Research